ArticleCancers2022

Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma.

Bianca Gautron Moura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.